BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 29966986)

  • 1. In vitro combinatorial anti-proliferative and immunosuppressive effects of Brucea javanica extract with CX-4945 and imatinib in human T-cell acute lymphoblastic leukemia cells.
    Jung JI; Kim SY; Park KY; Sydara K; Lee SW; Kim SA; Kim J
    Biomed Pharmacother; 2018 Oct; 106():403-410. PubMed ID: 29966986
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synergistic therapeutic effect of diethylstilbestrol and CX-4945 in human acute T-lymphocytic leukemia cells.
    Jung JI; Park KY; Kim SA; Kim J
    Biomed Pharmacother; 2018 Feb; 98():357-363. PubMed ID: 29275177
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anti-Proliferative Effect of
    Kim J; Lee DH; Badamtsetseg B; Lee S; Kim SA
    Molecules; 2020 Dec; 26(1):. PubMed ID: 33374788
    [No Abstract]   [Full Text] [Related]  

  • 4. The apoptotic effects of
    Bagheri E; Hajiaghaalipour F; Nyamathulla S; Salehen N
    Drug Des Devel Ther; 2018; 12():657-671. PubMed ID: 29636600
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Marsdenia tenacissimae extraction (MTE) inhibits the proliferation and induces the apoptosis of human acute T cell leukemia cells through inactivating PI3K/AKT/mTOR signaling pathway via PTEN enhancement.
    Wang Y; Chen B; Wang Z; Zhang W; Hao K; Chen Y; Li K; Wang T; Xie Y; Huang Z; Tong X
    Oncotarget; 2016 Dec; 7(50):82851-82863. PubMed ID: 27756877
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synergistic cytotoxic effects of bortezomib and CK2 inhibitor CX-4945 in acute lymphoblastic leukemia: turning off the prosurvival ER chaperone BIP/Grp78 and turning on the pro-apoptotic NF-κB.
    Buontempo F; Orsini E; Lonetti A; Cappellini A; Chiarini F; Evangelisti C; Evangelisti C; Melchionda F; Pession A; Bertaina A; Locatelli F; Bertacchini J; Neri LM; McCubrey JA; Martelli AM
    Oncotarget; 2016 Jan; 7(2):1323-40. PubMed ID: 26593250
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Brucea javanica oil induces apoptosis in T24 bladder cancer cells via upregulation of caspase-3, caspase-9, and inhibition of NF-kappaB and COX-2 expressions.
    Lou GG; Yao HP; Xie LP
    Am J Chin Med; 2010; 38(3):613-24. PubMed ID: 20503476
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Brucea javanica: A review on anticancer of its pharmacological properties and clinical researches.
    Li KW; Liang YY; Wang Q; Li Y; Zhou SJ; Wei HC; Zhou CZ; Wan XH
    Phytomedicine; 2021 Jun; 86():153560. PubMed ID: 33858739
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anti-inflammatory activity of ethyl acetate fraction of the seeds of Brucea Javanica.
    Yang J; Li S; Xie C; Ye H; Tang H; Chen L; Peng A
    J Ethnopharmacol; 2013 May; 147(2):442-6. PubMed ID: 23538165
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of protein kinase CK2 by CX-5011 counteracts imatinib-resistance preventing rpS6 phosphorylation in chronic myeloid leukaemia cells: new combined therapeutic strategies.
    Salizzato V; Borgo C; Cesaro L; Pinna LA; Donella-Deana A
    Oncotarget; 2016 Apr; 7(14):18204-18. PubMed ID: 26919095
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anti-proliferative effect of RCE-4 from Reineckia carnea on human cervical cancer HeLa cells by inhibiting the PI3K/Akt/mTOR signaling pathway and NF-κB activation.
    Bai C; Yang X; Zou K; He H; Wang J; Qin H; Yu X; Liu C; Zheng J; Cheng F; Chen J
    Naunyn Schmiedebergs Arch Pharmacol; 2016 Jun; 389(6):573-84. PubMed ID: 26935715
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combined Casein Kinase II inhibition and epigenetic modulation in acute B-lymphoblastic leukemia.
    Richter A; Roolf C; Hamed M; Gladbach YS; Sender S; Konkolefski C; Knübel G; Sekora A; Fuellen G; Vollmar B; Murua Escobar H; Junghanss C
    BMC Cancer; 2019 Mar; 19(1):202. PubMed ID: 30841886
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Seed oil of Brucea javanica induces apoptosis through the PI3K/Akt signaling pathway in acute lymphocytic leukemia Jurkat cells.
    Zhang H; Yin SL; Wang LH; Jia LN; Su GY; Liu XQ; Zhou F; Breslin P; Meng R; Li QY; Yang JY; Wu CF
    Chin J Nat Med; 2021 Aug; 19(8):608-620. PubMed ID: 34419260
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anti-inflammatory effects of Brucea javanica oil emulsion by suppressing NF-κB activation on dextran sulfate sodium-induced ulcerative colitis in mice.
    Huang YF; Zhou JT; Qu C; Dou YX; Huang QH; Lin ZX; Xian YF; Xie JH; Xie YL; Lai XP; Su ZR
    J Ethnopharmacol; 2017 Feb; 198():389-398. PubMed ID: 28119098
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antiproliferative and apoptosis-inducing activity of Brucea javanica extract on human carcinoma cells.
    Lau FY; Chui CH; Gambari R; Kok SH; Kan KL; Cheng GY; Wong RS; Teo IT; Cheng CH; Wan TS; Chan AS; Tang JC
    Int J Mol Med; 2005 Dec; 16(6):1157-62. PubMed ID: 16273300
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tetrandrine and cepharanthine induce apoptosis through caspase cascade regulation, cell cycle arrest, MAPK activation and PI3K/Akt/mTOR signal modification in glucocorticoid resistant human leukemia Jurkat T cells.
    Xu W; Wang X; Tu Y; Masaki H; Tanaka S; Onda K; Sugiyama K; Yamada H; Hirano T
    Chem Biol Interact; 2019 Sep; 310():108726. PubMed ID: 31255635
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phytochemical and biological activities of an anticancer plant medicine: Brucea javanica.
    Zhao L; Li C; Zhang Y; Wen Q; Ren D
    Anticancer Agents Med Chem; 2014 Mar; 14(3):440-58. PubMed ID: 24066797
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Effect of Brucea Javanica Oil Emulsion on the Invasiveness of Glioma Cells and Its Possible Mechanism].
    Qin LJ; Jia YS; Zhao XQ; Zhang T; Zhang W; Sun N
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2016 May; 47(3):347-50. PubMed ID: 27468478
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Therapeutic effect of Brucea javanica oil emulsion on experimental Crohn's disease in rats: Involvement of TLR4/ NF-κB signaling pathway.
    Huang YF; Li QP; Dou YX; Wang TT; Qu C; Liang JL; Lin ZX; Huang XQ; Su ZR; Chen JN; Xie YL
    Biomed Pharmacother; 2019 Jun; 114():108766. PubMed ID: 30901719
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Triple Akt inhibition as a new therapeutic strategy in T-cell acute lymphoblastic leukemia.
    Cani A; Simioni C; Martelli AM; Zauli G; Tabellini G; Ultimo S; McCubrey JA; Capitani S; Neri LM
    Oncotarget; 2015 Mar; 6(9):6597-610. PubMed ID: 25788264
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.